Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Mirjana Gotić"'
Autor:
Vladan P. Čokić, Olivera Mitrović-Ajtić, Bojana B. Beleslin-Čokić, Dragana Marković, Marijana Buač, Miloš Diklić, Nada Kraguljac-Kurtović, Svetozar Damjanović, Pavle Milenković, Mirjana Gotić, Puri K. Raj
Publikováno v:
Mediators of Inflammation, Vol 2015 (2015)
The recent JAK1/2 inhibitor trial in myeloproliferative neoplasms (MPNs) showed that reducing inflammation can be more beneficial than targeting gene mutants. We evaluated the proinflammatory IL-6 cytokine and JAK-STAT signaling pathway related genes
Externí odkaz:
https://doaj.org/article/4875d06e34dc42e5aa02a133763630c9
Autor:
Vladan P Čokić, Pascal Mossuz, Jing Han, Nuria Socoro, Bojana B Beleslin-Čokić, Olivera Mitrović, Tijana Subotički, Miloš Diklić, Danijela Leković, Mirjana Gotić, Raj K Puri, Constance Tom Noguchi, Alan N Schechter
Publikováno v:
PLoS ONE, Vol 10, Iss 8, p e0135463 (2015)
The gene and protein expression profiles in myeloproliferative neoplasms (MPNs) may reveal gene and protein markers of a potential clinical relevance in diagnosis, treatment and prediction of response to therapy. Using cDNA microarray analysis of 25,
Externí odkaz:
https://doaj.org/article/8d9ce0abca2c48949eaad05baeb2d422
Autor:
Sunčica Kapor, Sanja Momčilović, Slobodan Kapor, Slavko Mojsilović, Milica Radojković, Milica Apostolović, Branka Filipović, Mirjana Gotić, Vladan Čokić, Juan F. Santibanez
Publikováno v:
Advances in Experimental Medicine and Biology ISBN: 9783031261626
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::15420da7f7ede4a1263392b4e76bacf0
https://doi.org/10.1007/978-3-031-26163-3_15
https://doi.org/10.1007/978-3-031-26163-3_15
Autor:
Milica Vukotić, Sunčica Kapor, Teodora Dragojević, Dragoslava Đikić, Olivera Mitrović Ajtić, Miloš Diklić, Tijana Subotički, Emilija Živković, Bojana Beleslin Čokić, Aleksandar Vojvodić, Juan F. Santibáñez, Mirjana Gotić, Vladan P. Čokić
Publikováno v:
Experimental & Molecular Medicine
Although bone marrow-derived mesenchymal stromal cells (BM-MSCs) have been identified as a major cellular source of fibrosis, the exact molecular mechanism and signaling pathways involved have not been identified thus far. Here, we show that BM-MSCs
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68907a30a483855bfcd20e9456bdae3e
http://rimi.imi.bg.ac.rs/bitstream/id/2710/Inhibition_of_proinflammatory_signaling_impairs_fibrosis_pub_2022.pdf
http://rimi.imi.bg.ac.rs/bitstream/id/2710/Inhibition_of_proinflammatory_signaling_impairs_fibrosis_pub_2022.pdf
Autor:
Tijana, Subotički, Olivera, Mitrović Ajtić, Bojana B, Beleslin-Čokić, Sunčica, Bjelica, Dragoslava, Djikić, Miloš, Diklić, Danijela, Leković, Mirjana, Gotić, Juan F, Santibanez, Constance T, Noguchi, Vladan P, Čokić
Publikováno v:
Cell biology international. 43(2)
Myeloproliferative neoplasms (MPNs) are developing resistance to therapy by JAK1/2 inhibitor ruxolitinib. To explore the mechanism of ruxolitinib’s limited effect, we examined the JAK1/2 mediated induction of proliferation related ERK1/2 and AKT si
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::858a9823297ed6bde09e1b94ac78f47e
https://pubmed.ncbi.nlm.nih.gov/30571852
https://pubmed.ncbi.nlm.nih.gov/30571852
Autor:
Kai Wille, Maja Brouka, Johannes Bernhardt, Axel Rüfer, Emilia Niculescu-Mizil, Mirjana Gotic, Susanne Isfort, Steffen Koschmieder, Tiziano Barbui, Parvis Sadjadian, Tatjana Becker, Vera Kolatzki, Raphael Meixner, Hannah Marchi, Christiane Fuchs, Frank Stegelmann, Konstanze Döhner, Jean-Jacques Kiladjian, Martin Griesshammer
Publikováno v:
HemaSphere, Vol 7, Iss 5, p e882 (2023)
Externí odkaz:
https://doaj.org/article/b035eab057074d4ba4e409996281a096
Autor:
Ang Lin, Sven Brandau, Stephan Lang, Luca Cassetta, Kirsten Bruderek, Joanna Skrzeczynska-Moncznik, Oktawia Osiecka, Xiaoying Hu, Ida Marie Rundgren, Kim Santegoets, Utku Horzum, Ana Godinho-Santos, Gennadiy Zelinskyy, Thalia Garcia-Tellez, Sunčica Bjelica, Bartłomiej Taciak, Astrid Olsnes Kittang, Benedikt Höing, Michael Dixon, Verena Müller, Jochen Sven Utikal, Derya Karakoç, Kerim Bora Yilmaz, Emilia Górka, Lubomir Bodnar, Olympia Evdoxia Anastasiou, Christine Bourgeois, Robert Badura, Monika Kapinska-Mrowiecka, Mirjana Gotic, Mark ter Laan, Esther Kers-Rebel, Magdalena Król, Juan Francisco Santibañez, Michaela Müller-Trutwin, Ulf Dittmer, Ana Espada de Sousa, Güneş Esendağlı, Gosse Adema, Karin Loré, Elisabeth Ersvær, Viktor Umansky, Jeffrey W Pollard, Joanna Cichy
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
Background Myeloid-derived suppressor cells (MDSC) are a functional myeloid cell subset that includes myeloid cells with immune suppressive properties. The presence of MDSC has been reported in the peripheral blood of patients with several malignant
Externí odkaz:
https://doaj.org/article/a204127dcd8f4fbba35c1dcd217e919e